Peptide_NN
vaccination_NN
can_MD
lead_VB
to_TO
enhanced_VBN
tumor_NN
growth_NN
through_IN
specific_JJ
T-cell_NN
tolerance_NN
induction_NN
._.

Vaccination_NN
with_IN
synthetic_JJ
peptides_NNS
representing_VBG
cytotoxic_JJ
T_NN
lymphocyte_NN
-LRB-_-LRB-
CTL_NN
-RRB-_-RRB-
epitopes_NNS
can_MD
lead_VB
to_TO
a_DT
protective_JJ
CTL-mediated_JJ
immunity_NN
against_IN
tumors_NNS
or_CC
viruses_NNS
._.

We_PRP
now_RB
report_VBP
that_IN
vaccination_NN
with_IN
a_DT
CTL_NN
epitope_NN
derived_VBN
from_IN
the_DT
human_JJ
adenovirus_NN
type_NN
5_CD
E1A-region_NN
-LRB-_-LRB-
Ad5E1A234-243_NN
-RRB-_-RRB-
,_,
which_WDT
can_MD
serve_VB
as_IN
a_DT
target_NN
for_IN
tumor-eradicating_JJ
CTL_NN
,_,
enhances_VBZ
rather_RB
than_IN
inhibits_VBZ
the_DT
growth_NN
of_IN
Ad5E1A-expressing_JJ
tumors_NNS
._.

This_DT
adverse_JJ
effect_NN
of_IN
peptide_NN
vaccination_NN
was_VBD
rapidly_RB
evoked_VBN
,_,
required_VBD
low_JJ
doses_NNS
of_IN
peptide_NN
-LRB-_-LRB-
10_CD
micrograms_NNS
-RRB-_-RRB-
,_,
and_CC
was_VBD
achieved_VBN
by_IN
a_DT
mode_NN
of_IN
peptide_NN
delivery_NN
that_WDT
induces_VBZ
protective_JJ
T-cell-mediated_JJ
immunity_NN
in_IN
other_JJ
models_NNS
._.

Ad5E1A-specific_JJ
CTL_NN
activity_NN
could_MD
no_RB
longer_RBR
be_VB
isolated_VBN
from_IN
mice_NNS
after_IN
injection_NN
of_IN
Ad5E1A-peptide_NN
,_,
indicating_VBG
that_IN
tolerization_NN
of_IN
Ad5E1A-specific_JJ
CTL_NN
activity_NN
causes_VBZ
the_DT
enhanced_VBN
tumor_NN
outgrowth_NN
._.

In_IN
contrast_NN
to_TO
peptide_NN
vaccination_NN
,_,
immunization_NN
with_IN
adenovirus_NN
,_,
expressing_VBG
Ad5E1A_NN
,_,
induced_VBD
Ad5E1A-specific_JJ
immunity_NN
and_CC
prevented_VBD
the_DT
outgrowth_NN
of_IN
Ad5E1A-expressing_JJ
tumors_NNS
._.

These_DT
results_NNS
show_VBP
that_IN
immunization_NN
with_IN
synthetic_JJ
peptides_NNS
can_MD
lead_VB
to_TO
the_DT
elimination_NN
of_IN
anti-tumor_JJ
CTL_NN
responses_NNS
._.

These_DT
findings_NNS
are_VBP
important_JJ
for_IN
the_DT
design_NN
of_IN
safe_JJ
peptide-based_JJ
vaccines_NNS
against_IN
tumors_NNS
,_,
allogeneic_JJ
organ_NN
transplants_NNS
,_,
and_CC
T-cell-mediated_JJ
autoimmune_JJ
diseases_NNS
._.

